Serina Therapeutics, Inc. — Director's Dealing 2021

Jun 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AgeX Therapeutics, Inc. (AGE)
CIK: 0001708599
Period of Report: 2021-06-21

Reporting Person: MAY MICHAEL H (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-21	Option to Purchase Common Stock	$1.48	A	65000	Acquired	2031-06-20	Common Stock (65000)	Direct
2021-06-21	Option to Purchase Common Stock	$1.48	A	35000	Acquired	2031-06-20	Common Stock (35000)	Direct

Footnotes

F1: Options will vest and become exercisable in four equal quarterly installments on June 30, 2021, September 30, 2021, December 31, 2021, and March 31, 2022, provided that the grantee remains a director on the last day of the applicable calendar quarter.